Director for Education, Byers Center for Biodesign Associate Director of Surgery, School of Medicine
Dan Azagury is the Section chief of Minimally Invasive and Bariatric Surgery at Stanford University. He is a minimally invasive surgeon and a health technology innovator with an international background.
Dr. Azagury is the Director for Education for the fellowship program at the Stanford Byers Center for Biodesign. He teaches multidisciplinary teams a process to identify important healthcare needs and develop novel health technologies to address them. He also teaches in multiple international medical innovation programs and co-directs the Japan Biodesign partnership program.
Judy C. Boughey, M.D., is a researcher, professor, and clinician at the Mayo Clinic. She specializes in breast cancer research, treatment, and surgery and is the principal investigator of several clinical trials, including the Breast Cancer Genome Guided Therapy (BEAUTY) study. After completing her medical training in the U.K., Dr. Boughey was a surgical resident at the University of South Carolina and a fellow in breast surgical oncology at M.D. Anderson Cancer Center. Dr. Boughey currently serves as the chair of the Mayo Clinic’s Division of Surgery Research, the vice chair for research in Mayo’s Department of Surgery, and the director of the Mayo Clinic Multidisciplinary Breast Surgery Fellowship.
M.D., Ph.D., Psychiatrist in private practice & Medical Director of Psychiatric Services
David H. Brendel, M.D., Ph.D. is a Harvard-trained psychiatrist who practices in the Boston area. He maintains a private practice in Belmont, Massachusetts and serves as Medical Director of Psychiatric Services at Walden Behavioral Care in Waltham, Massachusetts. He received his M.D. from Harvard Medical School and his Ph.D. in philosophy from University of Chicago. Dr. Brendels academic work focuses on psychiatric ethics and the complex relationship between scientific and humanistic approaches in psychiatry.
Bill Brucker is in the clinical years of the M.D./Ph.D. program at Brown University. He completed his undergraduate education at Brown as well, playing football and graduating with honors in Chemistry in 2004. Brucker is the Founder & Executive Director of the Providence Alliance of Clinical Educators, a nonprofit organization that produces innovative lessons to help engage students in basic science learning. He has taught students of many levels over the years, including as an Adjunct Professor of Biology at Rhode Island College.
Michael Christman, Ph.D., is president and chief executive officer of the Coriell Institute for Medical Research. In 2007, Dr. Christman initiated the Coriell Personalized Medicine Collaborative (CPMC), a research study evaluating the utility of using the knowledge of genetics in medicine. Under Dr. Christmans leadership, Coriell has also established a federally-funded Induced Pluripotent Stem Cell lab. This remarkable technology allows a skin or blood cell to be coaxed into becoming nearly any cell type in the body, opening new avenues for research, drug discovery, and eventually therapy.
Director for Academic Programs, Byers Center for Biodesign Lecturer, School of Medicine
Lyn Denend is Director for Academic Programs at Stanford Biodesign and a Lecturer in the Stanford School of Medicine. In her Biodesign role, she leads curriculum development and program execution across Stanford Biodesign’s portfolio of educational offerings. She also teaches numerous courses and is the principal author of Biodesign: The Process of Innovating Medical Technologies.
Associate Professor, Psychiatry and Behavioral Sciences Assistant Professor, Biomedical Engineering
Kafui is an Associate Professor at Duke University with appointments in the Departments of Psychiatry and Behavioral Sciences, Neurobiology, Biomedical Engineering, and Neurosurgery. His ultimate goal is to combine his research, medical training, and community experience to improve outcomes for diverse communities suffering from Neurological and Psychiatric illness.
Ph.D. Candidate in Microbiology and Immunobiology, Harvard Medical School
Sarah received her B.S. in Biology from the Georgia Institute of Technology in 2007. That same year she started graduate school at Harvard Medical School, where she is currently pursuing her Ph.D. in immunology and conducting research on the immune response to intracellular bacterial pathogens.
Lynn Fiellin, M.D., is an Associate Professor at Yale University School of Medicine and a practicing physician. Her research and clinical practice focus on developing models and interventions for optimizing prevention and treatment, with a specific focus on HIV and substance use disorders.
Professor of Oncology Associate Professor of Pharmacology
Matthew P. Goetz, M.D., is a researcher, professor, and clinician at the Mayo Clinic. He has been the principal investigator of several clinical trials focused on the integration of pharmacogenomics into cancer treatment and the development of novel therapeutics in this area. He currently co-leads Mayo’s Breast Cancer Genome Guided Therapy (BEAUTY) study. After receiving his medical degree from University of North Dakota, Dr. Goetz completed training in internal medicine at University of Michigan. Dr. Goetz is currently the chair of the Breast Cancer Disease-Oriented Group at Mayo, co-leader of Mayo’s Womens Cancer Program, and deputy director of the Mayo Clinic’s Breast Cancer Specialized Program of Research Excellence (SPORE).
Patti Krautscheid is a certified genetic counselor with ARUP Laboratories, a national clinical reference laboratory and an enterprise of the University of Utahs Department of Pathology. She specializes in clinical molecular and genomic testing for inherited disorders. Krautscheid has an M.S. in Genetic Counseling from University of Michigan and a B.S. in Biology from University of Wisconsin–LaCrosse.
Founder, iRhythm Technologies, Inc. Fellow, Biodesign Innovation
Uday Kumar is the Founder of iRhythm, which is a digital healthcare company that is seeking to redefine the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The Zio Patch is a discreet, comfortable, patient-friendly monitoring patch that resembles an adhesive bandage.
Professor of Psychiatry & Human Behavior and of Pediatrics, Warren Alpert Medical School
Barry M. Lester is a Professor of Psychiatry & Human Behavior and a Professor of Pediatrics at Brown Universitys Warren Alpert Medical School. He is also Director of the Brown Center for the Study of Children at Risk at the Medical School and Women & Infants Hospital.
Director, Center for the Study of Children at Risk, Department of Psychiatry and Human Behavior
Barry M. Lester, Ph.D. is Professor of Psychiatry & Human Behavior and Pediatrics and Director of the Brown Center for the Study of Children at Risk at the Brown Alpert Medical School and Women & Infants Hospital.
Director, Autism and Developmental Medicine Institute
Christa Lese Martin, Ph.D., FACMG, is the Director of the Autism and Developmental Medicine Institute and Senior Investigator at Geisinger Health System. Previously, Dr. Martin was an Associate Professor at Emory University and Senior Lab Director of the Emory Genetics Lab. Her research interests include the identification and characterization of chromosomal imbalances involved in neurodevelopmental disorders and the rapid translation of new technologies for copy-number variation detection into the diagnostic arena for postnatal and prenatal testing.
Jin Kim Montclare is a Professor in the Department of Chemical and Biomolecular Engineering, who is performing groundbreaking research in engineering proteins to mimic nature and, in some cases, work better than nature. She works to customize artificial proteins with the aim of targeting human disorders, drug delivery and tissue regeneration as well as create nanomaterials for electronics.
Cecilia and Dan Carmichael Family Associate Director, Center for Individualized Medicine (Florida)
Alexander Parker, Ph.D., is a professor of Epidemiology and Urology at the Mayo Clinic. He is also the Cecilia and Dan Carmichael Family Associate Director of the Center for Individualized Medicine at the Mayo Clinic in Florida, which was launched in 2012 to advance research and clinical practice in the field of individualized medicine. Dr. Parkers research aims to improve our understanding of the molecular epidemiology of kidney cancer, with a particular focus on addressing clinical and public health questions. He received his Ph.D. in epidemiology from the University of Iowa and completed a post-doctoral fellowship in molecular and genetic epidemiology at the Mayo Clinic.